Skip to content

BioNexus Gene Lab Corp.: 10-Q filed 2019-08-09

What BioNexus Gene Lab Corp. reported in its quarterly report filed 2019-08-09 (fiscal Q2 2019): 30 published measures, 76 facts as tagged in accession 0001551163-19-000195.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-09
Fiscal period
fiscal Q2 2019
Accession
0001551163-19-000195 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioNexus Gene Lab Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-301,512,903USD
At 2018-12-311,652,239USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-30123,297USD
At 2018-12-31130,313USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-301,389,606USD
At 2018-12-311,521,926USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-12-311,260,239USD
At 2017-12-31839,145USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-70,398USD91
2019-01-01 to 2019-06-30-131,865USD181
2018-04-01 to 2018-06-30-39,472USD91
2018-01-01 to 2018-06-30178,388USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-101,496USD181
2018-01-01 to 2018-06-30-694,394USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-06-309,204USD181
2018-01-01 to 2018-06-3024,477USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-04-01 to 2019-06-3021,645USD91
2019-01-01 to 2019-06-3049,733USD181
2018-04-01 to 2018-06-30111,296USD91
2018-01-01 to 2018-06-30111,296USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-8,701USD181
2018-01-01 to 2018-06-301,238,149USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-9,204USD181
2018-01-01 to 2018-06-30-36,857USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-218,707USD
At 2018-12-31-86,842USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-04-01 to 2019-06-301,179USD91
2019-01-01 to 2019-06-302,443USD181
2018-04-01 to 2018-06-300USD91
2018-01-01 to 2018-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-06-30330,055USD
At 2018-12-31341,805USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-69,219USD91
2019-01-01 to 2019-06-30-129,422USD181
2018-04-01 to 2018-06-30-39,472USD91
2018-01-01 to 2018-06-30178,388USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-301,170,778USD
At 2018-12-311,298,354USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-3064,168USD
At 2018-12-3162,893USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-06-305,940USD
At 2018-12-3115,301USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-304,625USD91
2019-01-01 to 2019-06-3013,891USD181
2018-04-01 to 2018-06-3025,650USD91
2018-01-01 to 2018-06-3013,120USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-04-01 to 2019-06-3017,020USD91
2019-01-01 to 2019-06-3035,842USD181
2018-04-01 to 2018-06-3085,646USD91
2018-01-01 to 2018-06-3098,176USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-3074,627,558shares
At 2018-12-3174,627,558shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-06-30-5,011,891USD
At 2018-12-31-5,011,891USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-06-30-27,432USD
At 2018-12-31-26,977USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2019-06-30404,991USD
At 2018-12-31395,504USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-06-3077,459USD
At 2018-12-3156,466USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-72,416USD91
2019-01-01 to 2019-06-30-132,320USD181
2018-04-01 to 2018-06-30-53,916USD91
2018-01-01 to 2018-06-30165,697USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-3081,224USD91
2019-01-01 to 2019-06-30157,712USD181
2018-04-01 to 2018-06-3067,894USD91
2018-01-01 to 2018-06-30104,483USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-06-3020,954USD181
2018-01-01 to 2018-06-3020,803USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-06-301,491USD181
2018-01-01 to 2018-06-301,964USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-06-300USD181
2018-01-01 to 2018-06-301,233,374USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-309,360USD181
2018-01-01 to 2018-06-308,379USD181

Inspect the source

Entity
BioNexus Gene Lab Corp. / CIK 0001737523
Captured
2026-09-21T17:25:37.348Z
SEC response SHA-256
eebcf668b9e42f0c31bf1fe5b3c17450d7f4d836f715c9cebcc6a4fafbcff983

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001737523.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))